Based on SEC filing data. A biotech corporation based in New York has raised $200 million in equity funding and is at the growth stage of development.
Get notified the moment IMMUNIC, INC. (IMUX) files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.